Layoffs at Apellis Pharmaceuticals
- Layoff events
- 2
- verified and sourced
- Roles reported
- 265
- roles in total
- Announced between
- Aug 2023 to Jan 2025
- Reported by
- Apellis Pharmaceuticals, Apellis Pharmaceuticals / SEC, and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Apellis Pharmaceuticals: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals |
Restructuring
Apellis Pharmaceuticals said it would reduce its ex-U.S. footprint by approximately 40 employees as it prioritized U.S. commercialization of Syfovre. |
40 | Not known | Ex-U.S. commercial footprint |
2 sources for Apellis Pharmaceuticals |
|
| Apellis Pharmaceuticals |
Restructuring
Apellis Pharmaceuticals announced a workforce reduction of around 225 employees, about 25% of staff, while cutting preclinical programs and targeting cost savings. |
225 | Not known | United States |
1 source for Apellis Pharmaceuticals |
Where this comes from
Every cut listed for Apellis Pharmaceuticals was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Apellis Pharmaceuticals? Tell us on our Discord and we will check it.